NDC 67544-106

Lovastatin

Lovastatin

Lovastatin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions -. The primary component is Lovastatin.

Product ID67544-106_8eccf91e-8dd6-406a-bfe2-a45d49012d13
NDC67544-106
Product TypeHuman Prescription Drug
Proprietary NameLovastatin
Generic NameLovastatin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2001-12-17
Marketing CategoryANDA / ANDA
Application NumberANDA075636
Labeler NameAphena Pharma Solutions -
Substance NameLOVASTATIN
Active Ingredient Strength20 mg/1
Pharm ClassesHMG-CoA Reducta
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 67544-106-80

180 TABLET in 1 BOTTLE, PLASTIC (67544-106-80)
Marketing Start Date2001-12-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67544-106-45 [67544010645]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-08-17
Marketing End Date2019-03-31

NDC 67544-106-30 [67544010630]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-06-15
Marketing End Date2019-03-31

NDC 67544-106-60 [67544010660]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-08-17
Marketing End Date2019-03-31

NDC 67544-106-80 [67544010680]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-03-29
Marketing End Date2019-03-31

NDC 67544-106-15 [67544010615]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-05-07
Marketing End Date2019-03-31

NDC 67544-106-53 [67544010653]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075636
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-06-15
Marketing End Date2019-03-31

Drug Details

Pharmacological Class

  • HMG-CoA Reductase Inhibitor [EPC]
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

NDC Crossover Matching brand name "Lovastatin" or generic name "Lovastatin"

NDCBrand NameGeneric Name
0093-0576LovastatinLovastatin
0093-0926LovastatinLovastatin
0093-0928LovastatinLovastatin
0185-0070LovastatinLovastatin
0185-0072LovastatinLovastatin
0185-0074LovastatinLovastatin
0440-6694LovastatinLovastatin
0615-5589LovastatinLovastatin
0615-6551LovastatinLovastatin
0615-6590LovastatinLovastatin
0615-7674LovastatinLovastatin
0615-7679LovastatinLovastatin
0615-7685LovastatinLovastatin
0615-7690LovastatinLovastatin
0615-8151Lovastatinlovastatin
0615-8152Lovastatinlovastatin
10544-235LovastatinLovastatin
10544-241LovastatinLovastatin
10544-242LovastatinLovastatin
10544-246LovastatinLovastatin
21695-534LovastatinLovastatin
21695-535LovastatinLovastatin
21695-536LovastatinLovastatin
33261-547LovastatinLovastatin
33261-548LovastatinLovastatin
33261-549LovastatinLovastatin
35356-885LovastatinLovastatin
42254-025LovastatinLovastatin
42254-028LovastatinLovastatin
42254-106LovastatinLovastatin
68001-224LovastatinLovastatin
68001-315LovastatinLovastatin
68001-316LovastatinLovastatin
68001-214LovastatinLovastatin
68001-314LovastatinLovastatin
68071-3108LovastatinLovastatin
68071-1973LovastatinLovastatin
68071-3127LovastatinLovastatin
68071-3261LovastatinLovastatin
68071-3397LovastatinLovastatin
68071-4271LovastatinLovastatin
68084-559LovastatinLovastatin
68180-468LovastatinLovastatin
68180-467LovastatinLovastatin
68180-469LovastatinLovastatin
68645-576LovastatinLovastatin
68645-566LovastatinLovastatin
68788-2634LovastatinLovastatin
68645-567LovastatinLovastatin
68788-0926LovastatinLovastatin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.